These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29982588)

  • 1. Antigenic Drift of Influenza A(H7N9) Virus Hemagglutinin.
    Ning T; Nie J; Huang W; Li C; Li X; Liu Q; Zhao H; Wang Y
    J Infect Dis; 2019 Jan; 219(1):19-25. PubMed ID: 29982588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 220 mutation in the hemagglutinin of avian influenza A (H7N9) virus alters antigenicity during vaccine strain development.
    Liu L; Lu J; Li Z; Zhou J; Guo J; Li X; Liu J; Shu Y; Wang D
    Hum Vaccin Immunother; 2018 Mar; 14(3):532-539. PubMed ID: 29300686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L226Q Mutation on Influenza H7N9 Virus Hemagglutinin Increases Receptor-Binding Avidity and Leads to Biased Antigenicity Evaluation.
    Wang Y; Lv Y; Niu X; Dong J; Feng P; Li Q; Xu W; Li J; Li C; Li J; Luo J; Li Z; Liu Y; Tan YJ; Pan W; Chen L
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32796071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Single Amino Acid Substitution at Residue 218 of Hemagglutinin Improves the Growth of Influenza A(H7N9) Candidate Vaccine Viruses.
    Li X; Gao Y; Ye Z
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31270231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice.
    Wang Y; Wu J; Xue C; Wu Z; Lin Y; Wei Y; Wei X; Qin J; Zhang Y; Wen Z; Chen L; Liu GD; Cao Y
    Antiviral Res; 2017 Jul; 143():97-105. PubMed ID: 28408133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of single amino acid substitution at position 220 in the hemagglutinin glycoprotein on avian influenza H7N9 candidate vaccine virus.
    Liu L; Li Z; Zhou J; Lu J; Li X; Liu J; Xiao N; Wang D
    Virus Genes; 2021 Apr; 57(2):164-171. PubMed ID: 33606171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Molecular Determinants of Antibody Recognition and Antigenic Drift in the H3 Hemagglutinin of Swine Influenza A Virus.
    Abente EJ; Santos J; Lewis NS; Gauger PC; Stratton J; Skepner E; Anderson TK; Rajao DS; Perez DR; Vincent AL
    J Virol; 2016 Sep; 90(18):8266-80. PubMed ID: 27384658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino Acid Residue 217 in the Hemagglutinin Glycoprotein Is a Key Mediator of Avian Influenza H7N9 Virus Antigenicity.
    Chang P; Sealy JE; Sadeyen JR; Iqbal M
    J Virol; 2019 Jan; 93(1):. PubMed ID: 30282714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic characteristics of hemagglutinin and neuraminidase of avian influenza A (H7N9) virus in Guizhou province, 2014-2017].
    Wan YH; Zhuang L; Zheng QN; Ren LJ; Fu L; Jiang WJ; Tang GP; Zhang DZ; Li SJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Nov; 39(11):1465-1471. PubMed ID: 30462955
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R229I substitution from oseltamivir induction in HA1 region significantly increased the fitness of a H7N9 virus bearing NA 292K.
    Tang J; Zou SM; Zhou JF; Gao RB; Xin L; Zeng XX; Huang WJ; Li XY; Cheng YH; Liu LQ; Xiao N; Wang DY
    Emerg Microbes Infect; 2024 Dec; 13(1):2373314. PubMed ID: 38922326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection.
    Henry Dunand CJ; Leon PE; Huang M; Choi A; Chromikova V; Ho IY; Tan GS; Cruz J; Hirsh A; Zheng NY; Mullarkey CE; Ennis FA; Terajima M; Treanor JJ; Topham DJ; Subbarao K; Palese P; Krammer F; Wilson PC
    Cell Host Microbe; 2016 Jun; 19(6):800-13. PubMed ID: 27281570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a parainfluenza virus 5 (PIV5)-based H7N9 vaccine in mice and guinea pigs: antibody titer towards HA was not a good indicator for protection.
    Li Z; Gabbard JD; Johnson S; Dlugolenski D; Phan S; Tompkins SM; He B
    PLoS One; 2015; 10(3):e0120355. PubMed ID: 25803697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Escape Adaptive Mutations in the H7N9 Avian Influenza Hemagglutinin Protein Increase Virus Replication Fitness and Decrease Pandemic Potential.
    Chang P; Sealy JE; Sadeyen JR; Bhat S; Lukosaityte D; Sun Y; Iqbal M
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Potent Germline-like Human Monoclonal Antibody Targets a pH-Sensitive Epitope on H7N9 Influenza Hemagglutinin.
    Yu F; Song H; Wu Y; Chang SY; Wang L; Li W; Hong B; Xia S; Wang C; Khurana S; Feng Y; Wang Y; Sun Z; He B; Hou D; Manischewitz J; King LR; Song Y; Min JY; Golding H; Ji X; Lu L; Jiang S; Dimitrov DS; Ying T
    Cell Host Microbe; 2017 Oct; 22(4):471-483.e5. PubMed ID: 28966056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Mouse Monoclonal Antibodies Against the HA of A(H7N9) Influenza Virus.
    Ito M; Yamayoshi S; Murakami K; Saito K; Motojima A; Nakaishi K; Kawaoka Y
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30754701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of influenza A(H7N9) candidate vaccine viruses with improved hemagglutinin antigen yield in eggs.
    Ridenour C; Johnson A; Winne E; Hossain J; Mateu-Petit G; Balish A; Santana W; Kim T; Davis C; Cox NJ; Barr JR; Donis RO; Villanueva J; Williams TL; Chen LM
    Influenza Other Respir Viruses; 2015 Sep; 9(5):263-70. PubMed ID: 25962412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The stability and immunogenicity of inactivated MDCK cell-derived influenza H7N9 viruses.
    Tzeng TT; Lai CC; Weng TC; Cyue MH; Tsai SY; Tseng YF; Sung WC; Lee MS; Hu AY
    Vaccine; 2019 Nov; 37(47):7117-7122. PubMed ID: 31383484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preexisting human antibodies neutralize recently emerged H7N9 influenza strains.
    Henry Dunand CJ; Leon PE; Kaur K; Tan GS; Zheng NY; Andrews S; Huang M; Qu X; Huang Y; Salgado-Ferrer M; Ho IY; Taylor W; Hai R; Wrammert J; Ahmed R; García-Sastre A; Palese P; Krammer F; Wilson PC
    J Clin Invest; 2015 Mar; 125(3):1255-68. PubMed ID: 25689254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.